Publications by authors named "Danny Sheinson"

Claim this Profile
A
A rising tide lifts all boats in the personalized cancer care continuum for mNSCLC: bridging inequities in NGS fosters equity in targeted treatment.
Victor T G Lin, Esprit Ma, Neha Jain, Zhiyu Xia, Danny Sheinson

Oncologist· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Patient liability, treatment adherence, and treatment persistence associated with state bans of copay accumulator adjustment programs.
Achal Patel, Danny Sheinson, William B Wong

J Manag Care Spec Pharm· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-World Clinical and Economic Outcomes Among Persons With Multiple Sclerosis Initiating First- Versus Second- or Later-Line Treatment With Ocrelizumab.
Caroline K Geiger, Danny Sheinson, Tu My To, David Jones, Nicole G Bonine

Neurol Ther· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Costs associated with the use of multigene panel tests in three solid tumor types and the impact on insurance premiums.
William Wong, Danny Sheinson, Yutong Liu, Tu My To

Future Oncol· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Persistence and adherence to ocrelizumab compared with other disease-modifying therapies for multiple sclerosis in U.S. commercial claims data.
Natalie J Engmann, Danny Sheinson, Komal Bawa, Carmen D Ng, Gabriel Pardo

J Manag Care Spec Pharm· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis